Literature DB >> 1354856

Variable inhibition of cell-free translation by HIV-1 transcript leader sequences.

A P Geballe1, M K Gray.   

Abstract

The 5' ends of all human immunodeficiency virus type I (HIV-1) transcripts have the potential to coordinately regulate translation of HIV-1 mRNAs. Conflicting observations of the translational impact of these sequences in various systems stimulated these analyses of translation in reticulocyte lysates. We report a sensitive, rapid, quantitative, and inexpensive cell-free translation assay in which translational efficiency is monitored by enzymatic assay of the translation products. Using this assay and conventional radiolabeling assays, we demonstrate that the HIV-1 transcript leader inhibits downstream translation and that the stem-loop structure is required. Under our assay conditions, this inhibition occurs predominantly in cis and is not mediated by the 68 kD, interferon-induced, double-stranded RNA-activated kinase (p68). However, under other assay conditions the HIV-1 leader may activate p68 and inhibit translation in trans. We show that variation between individual preparations of cell-free extracts can dramatically alter the magnitude of the translational inhibition by the HIV-1 leader. Further, we provide evidence that a heat-labile factor is required for efficient translation of transcripts containing the HIV-1 leader. These observations provide a foundation for identifying factors required for translation of HIV-1 transcripts.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354856      PMCID: PMC334138          DOI: 10.1093/nar/20.16.4291

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

Review 1.  The HIV-1 Tat protein: an RNA sequence-specific processivity factor?

Authors:  B R Cullen
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

Review 2.  HIV TAR: an RNA enhancer?

Authors:  P A Sharp; R A Marciniak
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 3.  Regulation of gene expression in the human immunodeficiency virus type 1.

Authors:  B R Cullen
Journal:  Adv Virus Res       Date:  1991       Impact factor: 9.937

4.  The respective roles of the protein kinase and pppA2' p5' A2' p5 A-activated endonuclease in the inhibition of protein synthesis by double stranded RNA in rabbit reticulocyte lysates.

Authors:  B R Williams; C S Gilbert; I M Kerr
Journal:  Nucleic Acids Res       Date:  1979-04       Impact factor: 16.971

5.  Inhibition of mRNA binding to ribosomes by localized activation of dsRNA-dependent protein kinase.

Authors:  A De Benedetti; C Baglioni
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

6.  Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product.

Authors:  S Roy; M G Katze; N T Parkin; I Edery; A G Hovanessian; N Sonenberg
Journal:  Science       Date:  1990-03-09       Impact factor: 47.728

7.  The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase.

Authors:  S Roy; M Agy; A G Hovanessian; N Sonenberg; M G Katze
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  HIV-1 TAT "activates" presynthesized RNA in the nucleus.

Authors:  M Braddock; A Chambers; W Wilson; M P Esnouf; S E Adams; A J Kingsman; S M Kingsman
Journal:  Cell       Date:  1989-07-28       Impact factor: 41.582

9.  Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA.

Authors:  D N SenGupta; R H Silverman
Journal:  Nucleic Acids Res       Date:  1989-02-11       Impact factor: 16.971

10.  Mutational analysis of the 5' non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation.

Authors:  N T Parkin; E A Cohen; A Darveau; C Rosen; W Haseltine; N Sonenberg
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  30 in total

Review 1.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  The 5' RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNA.

Authors:  T M Roberts; K Boris-Lawrie
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.

Authors:  M Butsch; K Boris-Lawrie
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Inhibition of translation termination mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA.

Authors:  Deanna M Janzen; Lyudmila Frolova; Adam P Geballe
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

5.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

6.  The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.

Authors:  Viraj R Sanghvi; Laura F Steel
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

7.  Inhibition of nascent-peptide release at translation termination.

Authors:  J Cao; A P Geballe
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

8.  RU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA.

Authors:  Stacey Hull; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 9.  Translation-targeted therapeutics for viral diseases.

Authors:  J B Harford
Journal:  Gene Expr       Date:  1995

10.  The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.